Davidson Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-61,549
Closed -$2.63M – 101
2026
Q2
$2.63M Buy
61,549
+3,933
+7% +$214K 0.42% 55
2026
Q1
$3.62M Buy
57,616
+57,486
+44,220% +$4.6M 0.66% 47
2025
Q4
$12.4K Buy
+130
New +$12.7K ﹤0.01% 71
2023
Q1
– Sell
-52
Closed -$2.41K – 90
2022
Q4
$2.41K Buy
+52
New +$2.25K ﹤0.01% 109

Other funds holding BSX

Davidson Capital Management's BSX Position: Q3 2026 in Review

Davidson Capital Management sold out of Boston Scientific (BSX) in Q3 2026, closing a stake of 61,549 shares — an estimated $2.63M sold.

Davidson Capital Management first reported a position in BSX in Q4 2022 and held it in 4 quarters. The position peaked at $3.62M in Q1 2026. 515 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Davidson Capital Management reported no remaining Boston Scientific position as of Q3 2026 after selling out during the quarter.
  • Davidson Capital Management sold 61,549 Boston Scientific shares in Q3 2026, an estimated $2.63M.
  • Davidson Capital Management first reported a position in Boston Scientific in Q4 2022 and held it in 4 quarters.
  • Davidson Capital Management's Boston Scientific position peaked at $3.62M in Q1 2026.
  • 515 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Davidson Capital Management's 13F filing for Q3 2026, filed 15 Oct 2026.